Skip to main content
SpringerLink
Log in

Letter to the Editor

Regarding: Kraft S, Mackler E, Schlickman P, Welch K, DePestel DD (2011) Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients. Supp Care Cancer 19;1969–1974.

  • Letter to the Editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kraft S, Mackler E, Schlickman P, Welch K, DePestel DD (2011) Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients. Supp Care Cancer 19:1969–1974

    Article  Google Scholar 

  2. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64(2):328–340

    PubMed  CAS  Google Scholar 

  3. Elting LS, Rubenstein EB, Rolston KV, Bodey GP (1997) Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 25(2):247–259

    Article  PubMed  CAS  Google Scholar 

  4. Kullar R, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J et al (2011) High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter retrospective study. Pharmacotherapy 31(6):527–536

    Article  PubMed  CAS  Google Scholar 

  5. Tran TT, Palmer HR, Weston JS, Hirsch EB, Shah DN, Cottreau JM, et al (2011) High dose daptomycin (>mg/kg) for the treatment of non-urinary vancomycin-resistant enterococcal infections. (Abstract K-1477) IN: Proceedings of the 51st Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 17–20, 2011

  6. Steinrucken J, Perrottet N, Pannatier A, Borens O, Trampuz A (2011) High-dose daptomycin (>6 mg/kg) for treatment of severe infections due to staphylococci and enterococci. (Abstract K-1426) IN: Proceedings of the 51st Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 17–20, 2011

  7. Hall AD (2011) Evaluation of standard and high dose daptomycin versus linezolid against vancomycin-resistant Enterococcus faecium (VRE) in an in vitro model of simulated endocardial vegetations (SEV). (Abstract A2-018) IN: Proceedings of the 51st Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 17–20, 2011

  8. Rand KH, Houck H (2004) Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci. J Antimicrob Chemother 53:530–532

    Article  PubMed  CAS  Google Scholar 

  9. Rand KH, Huck H (2002) Daptomycin synergy with rifampin against vancomycin-resistant enterococci (Abstract K-1477). In: Proceedings of the 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 27–30, 2002

  10. Matar MJ, Tarrand J, Raad I, Rolston KV (2006) Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 34:534–536

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

This manuscript does not discuss my research, hence, I have nothing to declare.

Author information

Authors and Affiliations

  1. The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1460, Houston, TX, 77030, USA

    Kenneth V. Rolston

Authors
  1. Kenneth V. Rolston
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenneth V. Rolston.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rolston, K.V. Letter to the Editor. Support Care Cancer 20, 1117–1118 (2012). https://doi.org/10.1007/s00520-012-1419-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-012-1419-6

Keywords

Search

Navigation